BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12836016)

  • 1. Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate.
    Menges M; Schmidt C; Lindemann W; Ridwelski K; Pueschel W; Jüngling B; Feifel G; Schilling M; Stallmach A; Zeitz M
    J Cancer Res Clin Oncol; 2003 Jul; 129(7):423-9. PubMed ID: 12836016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.
    Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U
    Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer.
    Brenner B; Shah MA; Karpeh MS; Gonen M; Brennan MF; Coit DG; Klimstra DS; Tang LH; Kelsen DP
    Ann Oncol; 2006 Sep; 17(9):1404-11. PubMed ID: 16788003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
    Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann JT; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C
    Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response].
    Káposztás Z; Cseke L; Kalmár K; Horváth OP
    Magy Seb; 2002 Oct; 55(5):321-4. PubMed ID: 12474518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma.
    Alexander HR; Grem JL; Hamilton JM; Pass HI; Hong M; Fraker DL; Steinberg SM; McAtee N; Allegra BC; Johnston PG
    Cancer J Sci Am; 1995; 1(1):49-54. PubMed ID: 9166454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
    Ozdemir N; Abali H; Vural M; Yalcin S; Oksuzoglu B; Civelek B; Oguz D; Bostanci B; Yalcin B; Zengin N
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1139-47. PubMed ID: 25234436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study.
    Gallardo-Rincón D; Oñate-Ocaña LF; Calderillo-Ruiz G
    Ann Surg Oncol; 2000; 7(1):45-50. PubMed ID: 10674448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.
    Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N
    Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant chemotherapy for locally advanced gastric cancer].
    Kalmár K; Cseke L; Káposztás Z; Horváth G; Varga E
    Magy Seb; 2003 Oct; 56(5):177-84. PubMed ID: 15022621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.
    Wilke H; Preusser P; Fink U; Gunzer U; Meyer HJ; Meyer J; Siewert JR; Achterrath W; Lenaz L; Knipp H
    J Clin Oncol; 1989 Sep; 7(9):1318-26. PubMed ID: 2769330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
    Cascinu S; Labianca R; Graziano F; Pancera G; Barni S; Frontini L; Luporini G; Cellerino R; Catalano G
    Br J Cancer; 1998 Aug; 78(3):390-3. PubMed ID: 9703289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer.
    Graziano F; Santini D; Testa E; Catalano V; Beretta GD; Mosconi S; Tonini G; Lai V; Labianca R; Cascinu S
    Br J Cancer; 2003 Oct; 89(8):1428-32. PubMed ID: 14562012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
    Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program.
    Leichman L; Silberman H; Leichman CG; Spears CP; Ray M; Muggia FM; Kiyabu M; Radin R; Laine L; Stain S
    J Clin Oncol; 1992 Dec; 10(12):1933-42. PubMed ID: 1453207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent liposomal cisplatin (Lipoplatin), 5-fluorouracil and radiotherapy for the treatment of locally advanced gastric cancer: a phase I/II study.
    Koukourakis MI; Giatromanolaki A; Pitiakoudis M; Kouklakis G; Tsoutsou P; Abatzoglou I; Panteliadou M; Sismanidou K; Sivridis E; Boulikas T
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):150-5. PubMed ID: 20138443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial.
    Dalla Chiesa M; Tomasello G; Buti S; Rovere RK; Brighenti M; Lazzarelli S; Donati G; Passalacqua R
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):41-8. PubMed ID: 20204366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
    Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
    Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
    Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.